BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 11256225)

  • 1. [Treatment of acute stroke with systemic thrombolysis--benefit or risk?].
    Lyrer P; Fluri F
    Praxis (Bern 1994); 2001 Feb; 90(7):253-6. PubMed ID: 11256225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Thrombolytic therapy in acute ischemic stroke. Critical analysis of current knowledge].
    Murray V; Norrving B; Terént A; Wester P
    Lakartidningen; 2004 Feb; 101(8):662-8, 670-3. PubMed ID: 15024939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator does not benefit most eligible patients with stroke.
    Lansberg MG; Schwartz NE
    Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic thrombolysis in clinical practice: what have we learned after the Safe Implementation of Thrombolysis in Stroke Monitoring Study?
    Wahlgren N
    Cerebrovasc Dis; 2009; 27 Suppl 1():168-76. PubMed ID: 19342848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac papillary fibroelastoma: source of cerebral embolism treated with intravenous thrombolysis.
    Matijević V; Poljaković Z; Ilić I; Cikeš I; Habek M
    J Stroke Cerebrovasc Dis; 2011; 20(5):485-7. PubMed ID: 20692856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous tissue plasminogen activator (t-PA) for acute ischemic stroke in a local university hospital].
    Takahashi K; Iijima K; Oguro H; Bokura H; Nagai A; Yamaguchi S; Kobayashi S
    No To Shinkei; 2005 Aug; 57(8):683-8. PubMed ID: 16146212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-licensed 1-year experience of systemic thrombolysis with tissue plasminogen activator for ischemic stroke in a Japanese neuro-unit.
    Yoneda Y; Yamamoto S; Hara Y; Ohta K; Matsushita M; Yamamoto D; Yamashita H; Hosoda K
    Clin Neurol Neurosurg; 2007 Sep; 109(7):567-70. PubMed ID: 17573188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant tissue plasminogen activator for acute ischemic stroke.
    Al-Buhairi AR; Jan MM
    Saudi Med J; 2002 Jan; 23(1):13-9. PubMed ID: 11938357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D; Lorenzano S; Agnelli G; Guidetti D; Orlandi G; Semplicini A; Toso V; Caso V; Malferrari G; Fanucchi S; Bartolomei L; Prencipe M
    Cerebrovasc Dis; 2008; 25(1-2):129-35. PubMed ID: 18073466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy for acute ischemic stroke.
    Blakeley JO; Llinas RH
    J Neurol Sci; 2007 Oct; 261(1-2):55-62. PubMed ID: 17618652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis in the treatment of submassive pulmonary embolism.
    Mascitelli L; Pezzetta F
    Arch Intern Med; 2003 May; 163(10):1238; author reply 1238. PubMed ID: 12767964
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombolytic therapy in acute ischemic stroke patients with cardiac thrombus.
    Derex L; Nighoghossian N; Perinetti M; Honnorat J; Trouillas P
    Neurology; 2001 Dec; 57(11):2122-5. PubMed ID: 11739840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J; Frackowiak M; Zaro Weber O; Hahn M; Möller-Hartmann W; Rudolf J; Neveling M; Grond M; Schmulling S; Jacobs A; Heiss WD
    Cerebrovasc Dis; 2007; 24(1):56-65. PubMed ID: 17519545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.
    Bravo Y; Martí-Fàbregas J; Cocho D; Rodríguez-Yáñez M; Castellanos M; de la Ossa NP; Roquer J; Obach V; Maestre J; Martí-Vilalta JL
    Cerebrovasc Dis; 2008; 26(2):126-33. PubMed ID: 18560215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug; 13(72):127-31. PubMed ID: 15532135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous rtPA thrombolysis in acute ischemic stroke.
    Laloux P
    Acta Neurol Belg; 2001 Jun; 101(2):88-95. PubMed ID: 11486563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis for acute myocardial infarction: drug review.
    Cundiff DK
    MedGenMed; 2002 Jan; 4(1):1. PubMed ID: 11965203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.